Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab

• Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.

Detalles Bibliográficos
Autores principales: Wu, Meng, Bennett, Jennifer A., Reid, Pankti, Fleming, Gini F., Kurnit, Katherine C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326349/
https://www.ncbi.nlm.nih.gov/pubmed/34368414
http://dx.doi.org/10.1016/j.gore.2021.100837
_version_ 1783731791641706496
author Wu, Meng
Bennett, Jennifer A.
Reid, Pankti
Fleming, Gini F.
Kurnit, Katherine C.
author_facet Wu, Meng
Bennett, Jennifer A.
Reid, Pankti
Fleming, Gini F.
Kurnit, Katherine C.
author_sort Wu, Meng
collection PubMed
description • Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events.
format Online
Article
Text
id pubmed-8326349
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83263492021-08-06 Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab Wu, Meng Bennett, Jennifer A. Reid, Pankti Fleming, Gini F. Kurnit, Katherine C. Gynecol Oncol Rep Case Reports and Case Series • Metastatic SCC arising from the ovary is rare, and the optimal treatment is unknown. • Pembrolizumab successfully treated a patient with metastatic SCC. • Patients on pembrolizumab should be monitored for immune-related adverse events. Elsevier 2021-07-22 /pmc/articles/PMC8326349/ /pubmed/34368414 http://dx.doi.org/10.1016/j.gore.2021.100837 Text en © 2021 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Reports and Case Series
Wu, Meng
Bennett, Jennifer A.
Reid, Pankti
Fleming, Gini F.
Kurnit, Katherine C.
Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title_full Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title_fullStr Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title_full_unstemmed Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title_short Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
title_sort successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumab
topic Case Reports and Case Series
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326349/
https://www.ncbi.nlm.nih.gov/pubmed/34368414
http://dx.doi.org/10.1016/j.gore.2021.100837
work_keys_str_mv AT wumeng successfultreatmentofsquamouscellcarcinomaarisingfromapresumedovarianmaturecysticteratomawithpembrolizumab
AT bennettjennifera successfultreatmentofsquamouscellcarcinomaarisingfromapresumedovarianmaturecysticteratomawithpembrolizumab
AT reidpankti successfultreatmentofsquamouscellcarcinomaarisingfromapresumedovarianmaturecysticteratomawithpembrolizumab
AT flemingginif successfultreatmentofsquamouscellcarcinomaarisingfromapresumedovarianmaturecysticteratomawithpembrolizumab
AT kurnitkatherinec successfultreatmentofsquamouscellcarcinomaarisingfromapresumedovarianmaturecysticteratomawithpembrolizumab

Ejemplares similares